Fralex Therapeutics Inc. is dedicated to improving quality of life through the use of neuromodulation therapy. Our technology – known as the Complex Neural Pulse (CNP) – is being developed as a non-drug alternative for the treatment of chronic pain.

Further applications are planned in the treatment of depression and anxiety.

Press Releases

June 2, 2009 Fralex Purchased by Baylis

May 7, 2009 Fralex Announces First Quarter 2009 Results

April 17, 2009 Fralex Announces the Listing of its Common Shares on the NEX Board of the TSX Venture Exchange

March 30, 2009 Fralex Announces Reorganization And Sale Of Core Business To Baylis Medical Company Inc.

November 14, 2008 Fralex Provides Update On TSX Listing

October 2, 2008 Fralex Provides Update On RELIEF Trial

Note: The above documents are in PDF format.